CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-26 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −2,403 | $30.73 | $74K | 115,769 |
| 2026-02-26 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −5,410 | 10,819 | ||
| 2026-02-26 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +8,322 | 245,003 | ||
| 2026-02-26 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −3,695 | $30.73 | $114K | 241,308 |
| 2026-02-26 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −8,322 | 16,645 | ||
| 2026-02-26 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +6,866 | 96,438 | ||
| 2026-02-26 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −3,049 | $30.73 | $94K | 93,389 |
| 2026-02-26 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −6,866 | 13,732 | ||
| 2026-02-26 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +6,866 | 242,743 | ||
| 2026-02-26 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −3,049 | $30.73 | $94K | 239,694 |
| 2026-02-26 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −6,866 | 13,732 | ||
| 2026-02-23 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise | +2,283 | 13,340 | ||
| 2026-02-23 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Shares withheld for taxes | −672 | $32.19 | $22K | 12,668 |
| 2026-02-23 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise · Restricted Stock Unit Award | −2,283 | 2,284 | ||
| 2026-02-23 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +6,407 | 115,607 | ||
| 2026-02-23 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −2,845 | $32.19 | $92K | 112,762 |
| 2026-02-23 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −6,407 | 6,408 | ||
| 2026-02-23 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +8,738 | 240,561 | ||
| 2026-02-23 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −3,880 | $32.19 | $125K | 236,681 |
| 2026-02-23 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −8,738 | 8,738 |
Page 7 of 41 · 804 trades